The next phase of the response must not be about deploying more people into communities simply to deliver interventions.
Articles on Ebola Bundibugyo
Displaying all articles
The issue of internal displacement remains poorly understood despite the very large number of people involved.
Vaccine development can be really expensive, and there’s limited commercial return.
Geography may not provide meaningful protection once an outbreak is already underway.
The Ebola outbreak in the DRC has the potential to become huge and of long duration.
Uganda is the testing ground for a new vaccine that could work on more strains of the Ebola virus and other haemorrhagic fevers.
Top contributors
-
Professor in the faculty of Medicine, Mbarara University of Science and Technology
-
Assistant Professor of Epidemiology and Biostatistics, University of Illinois Chicago
-
Postdoctoral Researcher, Oxford Vaccine Group, University of Oxford
-
Calleva Head of Vaccine Immunology, University of Oxford
-
PhD Candidate, Paediatrics, University of Oxford
-
Director of the Refugee Law Initiative, School of Advanced Study, University of London
-
Senior lecturer, Njala University
-
Researcher, School of Medicine, Universidad de Alcalá